Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-331-625"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20120614.22.4-331-625"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I am delighted with the adoption of this motion for a resolution as it calls for strengthening controls on medical devices, particularly breast implants, in order to avoid another scandal like that of the PIP implants. These proposals should fuel the debate on the revision of the legislation on medical devices which should take place in the autumn. The PIP scandal has brought to light a malfunction at the European and national levels, notably a lack of cooperation between the authorities concerned and a lack of traceability of raw material used for medical devices. We have therefore called on the Commission to provide for a system of pre-market authorisation for certain products, particularly breast implants, and called for the introduction of an implant recipient’s ‘passport’ specifying the unique product code of the implant, its special characteristics and potential adverse effects, and an inventory of breast implants in each Member State. We have also called for the establishment of a system of collective redress to help consumers obtain compensation. With regard to market surveillance, Parliament is calling for the reinforcement of the information sharing system in order to guarantee better traceability of medical devices."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples